Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 21,120 shares at $55.35 ($1.2M) on 2026-04-21, disclosed to the SEC on 2026-04-23.
Scheduled sale ($1.2M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.35 | 1,625 | $90K | 7.8% |
| 2 | $56.17 | 5,415 | $304K | 26.3% |
| 3 | $54.29 | 7,040 | $382K | 33.0% |
| 4 | $54.07 | 6,619 | $358K | 30.9% |
| 5 | $54.56 | 421 | $23K | 2.0% |
| Total | $54.79 avg | 21,120 |
| $1.2M |
| 100% |
| Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |
| PAHC | SELL | 2026-03-26 | $2.3M | — | Filing → |